5 Indian Pharmacopoeia 2026 Updates Targeting Anti-Diabetic Drug Standards The release of the tenth edition of the Indian Pharmacopoeia in early 2026 marks a decisive turning point for pharmaceutical quality control across South Asia. With 121 new monographs specifically addressing anti-diabetic and metabolic disorder treatments, the Union Health Ministry is enforcing stricter drug purity and therapeutic bioequivalence standards at a moment when India's pharmaceutical...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai
English
French
Spanish
Italiano
Romaian
Portuguese (Brazil)
china